Molecular cytogenetics of childhood hematological malignancies

Leukemia

Volumn 11, Issue 12, 1997, Pages 1999-2021

  Martinez Climent, J A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Children; Cytogenetics; Leukemia; Lymphoblastic; Molecular analysis; Myeloid

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; EPIPODOPHYLLOTOXIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CLASSIFICATION; CANCER GENETICS; CHILDHOOD LEUKEMIA; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CYTOGENETICS; DRUG INDUCED CANCER; GENE REARRANGEMENT; HUMAN; LEUKEMIA CELL; MINIMAL RESIDUAL DISEASE; MYELODYSPLASTIC SYNDROME; NUMERICAL CHROMOSOME ABERRATION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVIEW; STRUCTURAL CHROMOSOME ABERRATION; TUMOR SUPPRESSOR GENE;

EID: 0031466118     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400842     Document Type: Review

References (15)

1. Pui C-H. Childhood leukemias. New Engl J Med 1995; 332: 1618-1630.
2. Rowley JD. Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 1990; 27: 122-136.
3. Pui-CH, Campana D, Crist WM. Towards a clinically useful classification of acute leukemias. Leukemia 1995; 9: 2154-2157.
4. Rubin CM, Rowley JD. Chromosomal abnormalities in childhood malignant diseases. In: Nathan DC, Oski FA (eds). Hematology of Infancy and Childhood. WB Saunders: Philadephia, 1993, pp 1288-1318.
5. Rowley JD, Golomb HM, Dougherty C. 15;17 translocation, a consistent change in acute promyelocytic leukemia. Lancet 1977; i: 549.
6. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 9: 2237-2251.
7. Carroll AJ, Crist WM, Parmley RT, Philips C, Krischer J, Head D, Gresik M, Ravindranath Y, Weinstein H. Pre-B cell leukemia associated with chromosome translocation 1;19. Blood 1984; 63: 721-726.
8. Keating MJ, Cork A, Broch Y, Smith T, Waltes RS, McCredie KB, Trujillo J, Freireich EJ. Towards a clinically relevant cytogenetic classification of acute myelogenous leukaemia. Leukemia Res 1987; 11: 119-133.
9. Rowley JD. Molecular cytogenetics: Rosetta stone for understanding cancer. Cancer Res 1990; 50: 3816-3825.
10. Weimberg RA. Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis. Cancer Res 1989; 49: 3713-3721.
11. Abbondazo SL, Medeiros J, Cossman J. Molecular genetics and its application to the diagnosis and classification of hematopoietic neoplasms. Am J Ped Hematol Oncol 1990; 12: 480-489.
12. Rowley JD, Aster JC, Sklar J. The impact of new DNA diagnostic technology on the management of cancer patients. Arch Pathol Lab Med 1993; 117: 1104-1109.
13. Chen C-S, Sorensen PHB, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993; 81: 2386-2393.
14. Campana D, Pui C-H. Detection of minimal residual disease in acute leukemia: methodological advances and clinical significance. Blood 1995; 6: 1416-1434.
15. Deisseroth AB. Current trends and future directions in the genetic therapy of human neoplastic disease. Cancer 1993; 72: 2069-2074.